Not recruitingISRCTN28588282
Agomelatine given orally compared to placebo, for depression
This study isn't currently recruiting.
In FranceDepression, BipolarityResearch studyAges 18+
Depression studies
Depression
Depression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.
Not recruitingISRCTN16339153
Evaluation of postpartum depression in patients undergoing cesarean section managed with an ERAS protocol
This study isn't currently recruiting.
In TurkeyDepressionResearch studyAges 18–40
Not recruitingISRCTN69603913
Internet-assisted therapy for adults with depressive symptoms: a study for the effectiveness of interpersonal therapy (IPT) compared to cognitive behaviour therapy (CBT)
This study isn't currently recruiting.
In AustraliaDepression, AnxietyResearch studyAges 18+
Not recruitingISRCTN66683128
PST4PPD: Problem Solving Therapy for Postpartum Depression, a home visit intervention for low-income Latina mothers
This study isn't currently recruiting.
In United StatesDepressionResearch studyAges 18+
CompletedEUCTR 2018-001963-22
A multicentre, double-blind, randomised, placebo - controlled phase II study to assess efficacy, safety and pharmacokinetics of inhaled Esketamine in subject with treatment-resistant depression in ...
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In PolandDepression, BipolarityHistorical research record
TerminatedEUCTR 2017-002232-16
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TAK-653 in the Treatment of Subjects with Treatment-Resistant Depression
This study ended early.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In United KingdomDepressionHistorical research record
TerminatedEUCTR 2006-006089-40
High dose corticosteroid pulses in treatment-resistant depression : a randomized double-blind placebo-controlled pilot study
This study ended early.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In United KingdomDepressionHistorical research record
CompletedEUCTR 2010-023414-31
Ketamine in treatment resistant major depression (TRD)
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In GermanyDepressionHistorical research record
CompletedEUCTR 2005-003251-13
Quetiapine Augmentation In Treatment-Resistant Depression – An Open Pilot Study
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In United KingdomDepressionHistorical research record
CompletedEUCTR 2015-003413-26
Understanding the molecular basis for the use of adjunctive anti-inflammatory treatment in treatment resistant depression: a stratified, randomised, placebo-controlled, experimental medicine study ...
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In United KingdomDepressionHistorical research record
WithdrawnNCT05268497
Feasibility of Using Clinician-directed and Digital Application Supported Cognitive Behavior Therapy for treatment-resistant depression
Official study title
Assessment of Feasibility of Using Clinician-Directed Cognitive Behavior Therapy Supplemented by a Digital Application in Conjunction With Esketamine (SPRAVATO®) in Participants With Treatment-Resistant Depression
This study was withdrawn before enrollment.
Multiple locations, including New HavenDepressionMedication studyAges 18–65
CompletedNCT00212797
2 Doses of Org 34517 for depression
What is this study about?
This study evaluated the safety and effectiveness of Org 34517 for people with depression.
This study has finished and is no longer accepting participants.
Location not clearly listedDepression, SchizophreniaMedication studyAges 18–70
Registry coverage
We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.